H.P. ACTHAR GEL
H.P. Acthar Gel is an adrenocorticotropic hormone indicated as monotherapy for the treatment of infantile spasms in infants and children under two years of age and for acute exacerbations of multiple sclerosis in adults. It is also indicated for the management of various rheumatic, collagen, dermatologic, allergic, ophthalmic, and respiratory diseases, often as adjunctive therapy for short-term administration or during acute exacerbations. Additionally, it is indicated for use in edematous states to induce diuresis or remission of proteinuria in nephrotic syndrome (without uremia).
How H.P. ACTHAR GEL Works
Acthar Gel stimulates the adrenal cortex to secrete cortisol, corticosterone, aldosterone, and various weak androgenic substances. While its exact mechanism for treating infantile spasms remains unknown, the drug is reported to bind to melanocortin receptors. The resulting increase in plasma cortisol levels suppresses the release of endogenous adrenocorticotropic hormone (ACTH) through a negative feedback mechanism. These trophic effects on the adrenal cortex are mediated by cyclic AMP. Prolonged administration of high doses can induce adrenal hyperplasia and hypertrophy.
Details
- Status
- Prescription
- First Approved
- 2010-10-15
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
H.P. ACTHAR GEL Approval History
What H.P. ACTHAR GEL Treats
8 indicationsH.P. ACTHAR GEL is approved for 8 conditions since its original approval in 2010. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Infantile Spasms
- Multiple Sclerosis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Systemic Lupus Erythematosus
- Dermatomyositis
- Erythema Multiforme
Drugs Similar to H.P. ACTHAR GEL
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
H.P. ACTHAR GEL FDA Label Details
ProIndications & Usage
FDA Label (PDF)Acthar Gel is indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age. Acthar Gel is indicated for the treatment of exacerbations of multiple sclerosis in adults. Acthar Gel may be used for the following disorders and diseases: rheumatic ; collagen ; dermatologic ; allergic states ; ophthalmic ; respiratory ; and edematous state. 1.1 Infantile Spasms Acthar Gel is indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age. 1.2 Multiple Sclerosis Acthar Gel is indicated for the treatment of acut...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.